We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Creating a Simulated Distribution Test
Email
Tweet

Creating a Simulated Distribution Test

Creating a Simulated Distribution Test
Ensure Your Products Reach Consumers Intact

Thursday, Jan. 21, 2016  • Postponed Until Further Notice
speaker

Your Expert Presenter

Roberta Goode,
President and CEO,
Goode Compliance International

Roberta Goode is an executive with over 25 years of experience in the medical device industry. She is currently President and CEO of Goode Compliance International (GCI), a global leader in engineering and compliance services for medical device manufacturers, specializing in process validation, design control and risk management. Prior to founding GCI in 2002, Ms. Goode held positions of increasing responsibility in R&D, Manufacturing and Quality Engineering at Beckman-Coulter Corporation, Althin Medical, Inc. (acquired by Baxter Healthcare) and Cordis Corporation (a Johnson & Johnson company), where she contributed intellectual property in the form of four U.S. patents for percutaneous cardiovascular interventional devices. She holds a Master of Science degree in Biomedical Engineering and a Bachelor of Science degree from the University of Miami. Additionally, Ms. Goode has an adjunct faculty appointment at the University of Miami’s College of Engineering and is an ASQ Certified Quality Engineer.

 

Webinar Details

whenWhen?  Thursday, Jan. 21, 2016

Register

This webinar been postponed until
further notice.  We are working to confirm
a new date.
 

Creating a Simulated Distribution Test
Ensure Your Products Reach Consumers Intact

Regardless of the type of regulated product you produce, it is good science, good business, and a worldwide regulatory and quality system requirement to validate that the packaging will protect the product’s integrity from the manufacturer’s shipping dock to the customer’s receiving dock. Failure to do so will prove costly to your company’s reputation and bottom line.

This is why it is vital for you to create a simulated distribution test to ensure that your product gets to where it needs to be in the condition it needs to be in.

Consider these two scenarios:

A drug product and its packaging were validated during the spring and summer prior to the product’s commercial debut; the launch of the product was scheduled for November. The first delivered batches of product arrived at the hospital after freezing during winter transport. The product had defrosted prior to use, but was inherently different, and in this case, ineffective for its intended use, having reached its freezing point.

A hospital regularly received a medical device that was sent overseas by cargo ship, and then delivered by truck or rail. An emergency caused the need for an urgent shipment of additional devices by airfreight. The product reached its destination in 48 hours, but the packaging had not been validated for air shipment. Upon its arrival, the customer found that the sterile barrier was breached, probably because of pressure changes with altitude, and the product was rendered unusable.

Both of these scenarios could have been made worse if the shipping damage had not been visually obvious; however damage to product and packaging are not always detectable with the naked eye. There are a number of non-obvious conditions and parameters to consider in the inclusion of package validation.

Join industry expert Roberta Goode on January 21st as she lays out all the conditions you need to be aware of while also providing a detailed breakdown of the steps you need to take to create a successful simulated distribution test. One that ensures your products don’t become damaged or a hazard en route to consumers.

In 90 minutes you’ll learn:

  • The 11 steps to successful simulated distribution testing
  • The three assurance levels for test intensity
  • How to use CAPA and risk analysis to address failures during testing
  • The 22 sets of regulations that may apply to your product

 

Who Should Attend

  • Auditors
  • Compliance officers
  • Engineering and design controls teams
  • Executive management
  • Managers
  • Manufacturing directors and supervisors
  • Pharmaceutical and cGMP auditors
  • QA/QC personnel
  • Risk management specialists
  • Strategic planning and business development staff
  • Validation specialists, scientists, engineers

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578

www.fdanews.com

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing